Fortis Malar Hospitals
- Market cap
- ₹ 76 Cr.
- P/E
- 22.9x
- P/B
- 2.23x
- 52-week range
- 39 – 68.75
- ROE
- 13%
- ROCE
- 14.7%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- BSE
About
Fortis Malar Hospitals Limited is an India-based healthcare service provider. The Company operates a multi-specialty hospital in Chennai, which is engaged in providing super specialty and multi-specialty healthcare services. The Company monitors and evaluates its outcomes for various procedures and specialties, which include coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA), kidney transplant, cesarean section and total knee replacement. Its patient-reported outcomes measurement (PROM) lends the voice of the patient to the entire process and helps enhance patient engagement and experience. The Company’s subsidiary is Malar Stars Medicare Limited.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Fortis Malar Hospitals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)22.9 against a typical 48.9: cheaper than most peers (1st = cheapest).7th of 40
- Sales growth−100% against a typical +21.1% from a year earlier.33rd of 34
- Profit growth−96.4% against a typical +13% from a year earlier.28th of 31
- Share price, 3 months−19% against a typical −10.9%.25th of 34
- Size₹ 75.9 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).29th of 36
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18 | 18 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 18 | 19 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Operating Profit | −0 | −1 | 0 | −1 | −0 | −0 | −0 | −0 | −0 | −0 | −1 | −0 |
| OPM % | −0.4% | −6.2% | 8.7% | — | — | — | — | −1,650% | −1,266.7% | — | — | — |
| Other Income | 2 | 1 | 60 | 1 | 1 | 1 | 1 | 5 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −2 | −4 | 59 | −0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Tax % | 0% | 0.3% | 8% | 0% | 0% | 93.3% | 10% | 3% | 92.9% | 89.5% | 136.4% | 25% |
| Net Profit | −2 | −4 | 54 | −0 | 0 | 0 | 0 | 4 | 0 | 0 | −0 | 0 |
| EPS in Rs | −0.96 | −2.13 | 28.84 | −0.03 | 0.05 | 0.01 | 0.19 | 2.21 | 0.01 | 0.01 | −0.03 | 0.08 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 50%
- 10 Years
- −5%
- 5 Years
- 18%
- 3 Years
- 31%
- TTM
- −97%
- 10 Years
- −3%
- 5 Years
- −7%
- 3 Years
- −5%
- TTM
- —
- 10 Years
- −5%
- 5 Years
- −8%
- 3 Years
- −2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Fortis Malar Hospitals | ₹ 40.50 | ₹ 76 Cr. | 22.9x | 2.2x | 13% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Pradeep Kumar Malhotra
- Chief Financial Officer
- Vinti Verma
- Company Secretary and Compliance Officer
Prices are delayed and for information only. Nothing on this page is investment advice.